TY - JOUR
T1 - Genetic/familial high-risk assessment
T2 - Colorectal, version 1.2021 featured updates to the NCCN Guidelines
AU - Weiss, Jennifer M.
AU - Gupta, Samir
AU - Burke, Carol A.
AU - Axell, Lisen
AU - Chen, Lee May
AU - Chung, Daniel C.
AU - Clayback, Katherine M.
AU - Dallas, Susan
AU - Felder, Seth
AU - Gbolahan, Olumide
AU - Giardiello, Francis M.
AU - Grady, William
AU - Hall, Michael J.
AU - Hampel, Heather
AU - Hodan, Rachel
AU - Idos, Gregory
AU - Kanth, Priyanka
AU - Katona, Bryson
AU - Lamps, Laura
AU - Llor, Xavier
AU - Lynch, Patrick M.
AU - Markowitz, Arnold J.
AU - Pirzadeh-Miller, Sara
AU - Samadder, Niloy Jewel
AU - Shibata, David
AU - Swanson, Benjamin J.
AU - Szymaniak, Brittany M.
AU - Wiesner, Georgia L.
AU - Wolf, Andrew
AU - Yurgelun, Matthew B.
AU - Zakhour, Mae
AU - Darlow, Susan D.
AU - Dwyer, Mary A.
AU - Campbell, Mallory
N1 - Publisher Copyright:
© JNCCN
PY - 2021/10
Y1 - 2021/10
N2 - Identifying individuals with hereditary syndromes allows for timely cancer surveillance, opportunities for risk reduction, and syndrome-specific management. Establishing criteria for hereditary cancer risk assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provides recommendations for the assessment and management of patients at risk for or diagnosed with high-risk colorectal cancer syndromes. The NCCN Genetic/Familial High-Risk Assessment: Colorectal panel meets annually to evaluate and update their recommendations based on their clinical expertise and new scientific data. These NCCN Guidelines Insights focus on familial adenomatous polyposis (FAP)/attenuated familial adenomatous polyposis (AFAP) syndrome and considerations for management of duodenal neoplasia.
AB - Identifying individuals with hereditary syndromes allows for timely cancer surveillance, opportunities for risk reduction, and syndrome-specific management. Establishing criteria for hereditary cancer risk assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provides recommendations for the assessment and management of patients at risk for or diagnosed with high-risk colorectal cancer syndromes. The NCCN Genetic/Familial High-Risk Assessment: Colorectal panel meets annually to evaluate and update their recommendations based on their clinical expertise and new scientific data. These NCCN Guidelines Insights focus on familial adenomatous polyposis (FAP)/attenuated familial adenomatous polyposis (AFAP) syndrome and considerations for management of duodenal neoplasia.
UR - http://www.scopus.com/inward/record.url?scp=85118253981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118253981&partnerID=8YFLogxK
U2 - 10.1164/jnccn.2021.0048
DO - 10.1164/jnccn.2021.0048
M3 - Article
C2 - 34666312
AN - SCOPUS:85118253981
SN - 1540-1405
VL - 19
SP - 1122
EP - 1132
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 10
ER -